In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications.
- Thousands of frontline health care workers risked their lives to save others during the pandemic. Some are suffering long-term complications of COVID-19. Yet there are no clear guidelines in most institutions to provide the necessary support to help their workers recover and return to work
- Without accommodations, COVID long-haulers may be forced to leave the health care workforce — at a time when COVID is surging again
Zeina N. Chemali, MD, MPH
Providers struggling with post-COVID complications will further strain the health care system unless medical institutions step up to support those who have sacrificed their health during the pandemic.
Massachusetts General Hospital
BOSTON — By mid-November, the Centers for Disease Control and Prevention had reported that 218,439 health care workers in the U.S. had been infected with COVID-19 — a likely underestimate due to incomplete data from states. About 3% to 4% of health care personnel who recover from coronavirus infection are expected to become “COVID long-haulers” as they cope with debilitating symptoms 12 to 18 months after the acute stage of the infection clears.
“As COVID-19 surges again, hospitals are facing a shortage of skilled frontline providers who can meet the relentless demands of caring for these patients,” says Zeina N. Chemali, MD, MPH, a psychiatrist and neurologist at Massachusetts General Hospital (MGH) and senior author of an article in Lancet Respiratory Medicine on the challenges of health care workers who are COVID long-haulers. “Providers struggling with post-COVID complications will further strain the health care system unless medical institutions step up to support those who have sacrificed their health during the pandemic.” Chemali directs MGH’s McCance Center for Brain Health and the neuropsychiatry clinic, which treat COVID survivors with lingering symptoms.
Long-term complications of COVID can affect multiple organs in the body. Some people suffer neuropsychiatric complaints, such as overwhelming fatigue, brain fog, persistent headaches, altered sleep, anxiety, post-traumatic stress disorder and difficulty concentrating. They may also have cardiopulmonary symptoms — fatigue after exertion, shortness of breath, persistent cough, heart arrhythmias, fluctuating blood pressure and fainting. Currently there are no curative treatments for post-COVID syndromes; therapy focuses on alleviating symptoms and coping strategies. Long-term complications of COVID can occur even in mild cases of the virus.
Chemali and her colleagues are calling for medical institutions to support and promote the safe return to work for all health care workers disabled from lingering symptoms of COVID. Current national return-to-work guidelines focus primarily on health care workers’ infection status, leaving institutions to establish their own policies or for employees to opt for medical or disability leave. While some institutions have made accommodations for health care personnel as they return to work post-COVID, the measures may not apply to all affected workers, exacerbating existing social inequities. In addition, the culture of medicine elevates duty to patients over personal needs, leaving behind the wellness of its workforce.
The authors recommend that multidisciplinary teams at medical institutions be charged with devising back-to-work strategies for health care workers with long-term COVID symptoms. These strategies might include a gradual reintroduction into the work force, limiting shifts so natural circadian rhythms aren’t disrupted, mandating frequent breaks and reducing workloads to prevent fatigue, and partnering with other providers to provide oversight during complex tasks and to share clinical responsibilities.
In addition, the authors are advocating for Congress to acknowledge the health issues and needs of long-hauler health care providers and for the new Biden administration to create funding to support health care workers as they recover from COVID. Previous U.S. government initiatives, such as the Coronavirus Aid, Relief, and Economic Security (CARES) Act, provided financial support to medical practices and hospitals struggling during the pandemic, but essential hospital workers disabled by the virus didn’t individually benefit from the funding, says Chemali.
Medical institutions and society have a moral obligation to support health care veterans of the COVID war, says Chemali, who studies mental health and neurological disorders among refugees and in people living in war zones. “Whether frontline providers are taking care of people in war zones or in hospitals filled with patients with COVID, they are working in dangerous, very uncertain and stressful environments,” says Chemali. “And yet they continue to perform their mission despite being overworked and burned out, which decreases their resilience and perhaps their immunity to the virus itself. We need to do better by health care workers who get sick with COVID. If we don’t help survivors of COVID recover and return to work as providers, institutions risk losing even more of their skilled personnel, who will succumb to the exhaustion and stress caused by this relentless COVID tsunami.”
Chemali is director of the Neuropsychiatry Clinic at MGH, unit chief of the McCance Center for Brain Health, and associate professor of Psychiatry and Neurology at Harvard Medical School (HMS). Nathan C. Praschan, MD, Sylvia Elena Josephy, MD, and David Dongkyung Kim, MD, are clinical fellows in Neuropsychiatry at MGH. Michael Kritzer-Cheren, MD, PhD, is an instructor in Psychiatry at HMS. Shibani Mukerji, MD, PhD, is associate director of the Neuro-infectious Diseases Unit at MGH and assistant professor of Neurology at HMS. Amy Newhouse, MD, is an instructor in Psychiatry at HMS. Marie Pasinski, MD, is assistant professor of Neurology at HMS and faculty at the McCance Center for Brain Health.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America’s Best Hospitals."
- Press Release
- Jul | 2 | 2021
Using a method developed for HIV, researchers have identified stable T cell vaccine targets in SARS-CoV-2.
- Press Release
- Jun | 23 | 2021
Skin problems can occur in some individuals after receiving a COVID-19 vaccine. Research by led by allergists at Massachusetts General Hospital (MGH) now provides encouraging indications that the reactions are rare, and they seldom recur after receiving a second vaccine dose.
- Press Release
- Jun | 23 | 2021
The MGH Center for Global Health is deploying a team on Thursday, June 24 to Mbarara, Uganda in collaboration with Build Health International to support efforts to treat patients with COVID-19 infections.
- Press Release
- Jun | 9 | 2021
An analysis of both inpatient and outpatient data within an integrated health system demonstrates the role of structural, societal factors in the pandemic’s spread.
- Press Release
- Jun | 8 | 2021
In 2020, people who smoked had a variety of responses to the COVID-19 pandemic, with some increasing their smoking to help them cope and others quitting to potentially lessen their vulnerability to COVID-19.